RecruitingNot ApplicableNCT06319300

Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards

Efficacy and Safety of the Artificial Intelligence-assisted Insulin Dose Adjustment System for Glycaemic Control in Patients With Type 2 Diabetes Mellitus in General Wards: a Multicentre, Single-blind, Randomised Controlled Study

Sponsor

Shanghai Zhongshan Hospital

Enrollment

140 participants

Start Date

Apr 19, 2024

Study Type

INTERVENTIONAL

Conditions

Diabetes Type 2

Summary

Our study was a single-blind, randomised, controlled, multicentre study. The study was planned to include 140 patients admitted to the general ward for subcutaneous insulin therapy, who were randomly divided into two groups in the ratio of 1:1, one group with an artificial intelligence assisted insulin dosimetry system to adjust the insulin dose to control their blood glucose, and the other group with a physician instituted insulin dosimetry adjustments to control their blood glucose. The effectiveness and safety of the system was confirmed by comparing the glycaemic control and risk of adverse events between the two groups.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests an AI-powered insulin dosing system in hospitalized patients with type 2 diabetes to see if it can keep blood sugar levels better controlled than standard care during a hospital stay. **You may be eligible if...** - You have been diagnosed with type 2 diabetes for more than 3 months - You are 18 years or older - You have been on blood sugar-lowering medication for at least 90 days - Your blood sugar is elevated but within a manageable range - Your planned hospital stay is at least 5 days **You may NOT be eligible if...** - You have type 1 diabetes or another special form of diabetes - Your blood sugar is extremely high, or you have a serious diabetes complication like diabetic ketoacidosis - You have a history of severe or repeated low blood sugar episodes - You have a BMI over 45, are pregnant, or have serious kidney, liver, or heart disease - You are on steroid-based hormone therapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.